Henri Beaufour

Net Worth

$3.359B

0% (24h)

Henri Beaufour is a French businessman and billionaire, primarily known for his stake in Ipsen, a global pharmaceutical company. His wealth originates from the healthcare industry, with a net worth of $3.4 billion as of December 2025. His career has been marked by his involvement in Ipsen Group, where he holds a board position, continuing the legacy of his family's pharmaceutical expertise. He holds a bachelor's degree from Georgetown University.

The Full Dossier

Early Life

Henri Pierre Albert Marie Beaufour was born in January 1965, in Neuilly-sur-Seine, France. He is the son of Albert Beaufour and the grandson of Dr. Henri Beaufour, who founded the Ipsen Group. He holds a bachelor's of arts from Georgetown University.

Rise to Success

Henri Beaufour's career has been centered around the pharmaceutical industry. He inherited a significant portion of his family's capital in Ipsen after his father's death in 2000. Along with his sister, Anne Beaufour, he controls approximately 52% of Ipsen.

Key Business Strategies

Henri Beaufour is a board member of Ipsen Group. He focuses on the strategic direction of the company. Under his leadership, Ipsen has expanded its global reach and maintained its position in the pharmaceutical market.

Philanthropy

Details on his specific philanthropic endeavors are not readily available in the search results.

Career Timeline

2000 - Present

Board Member, Ipsen

Serves on the Board of Directors of Ipsen and Mayroy.

2000

Inherited Stake in Ipsen

Inherited a significant portion of the family's capital in Ipsen after his father's death.

Philanthropic Impact

Category$XB

REAL initiative

REAL description